Education
About Us
Working with TipRanks
Follow Us
Kamada (KMDA)
NASDAQ:KMDA
Kamada Anti-Sars-Cov-2
COVID19, Pneumonia, Viral
Phase I/II
Completed
Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19
Sep 10, 2020
―
Glassia, Methylprednisolone Or Equivalent Steroid, Albumin
Graft Versus Host Disease
Phase II/III
Terminated
A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD
Oct 24, 2016
―
Kamrab - Hrig
Rabies
Phase III
Completed
Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
Sep 18, 2016
―
Glassia® And Institution Standard Of Care (Soc)
Transplantation, Lung Rejection
Phase II
Completed
Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation
Nov 15, 2015
―
Active Rabies Vaccine (Us-Fda Approved)
Rabies
Phase II/III
Completed
Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects
Nov 28, 2013
―
Alpha-1 Antitrypsin
New Onset Type-1 Diabetes
Phase II
Completed
Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes
Nov 27, 2013
―
Kamada-Aat For Inhalation, 80Mg, Kamada-Aat For Inhalation, 160Mg
Alpha-1 Antitrypsin Deficiency
Phase II
Completed
Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"
Nov 24, 2013
―
Alpha-1 Antitrypsin 40Mg (Aat, Glassia®), Alpha-1 Antitrypsin 60Mg (Aat, Glassia®), Alpha-1 Antitrypsin 80Mg (Aat, Glassia®)
Type 1 Diabetes Mellitus
Phase I/II
Completed
Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus
Feb 24, 2011
―
Kamada Aat For Inhalation
Emphysema
Phase II/III
Completed
International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema
Sep 15, 2010
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kamada (KMDA) have in its pipeline
KMDA is currently developing the following drugs: Kamada Anti-Sars-Cov-2, Alpha 1-Antitrypsin, Glassia, Methylprednisolone Or Equivalent Steroid, Albumin. These drug candidates are in various stages of clinical development as the company works toward FDA approval.